dc.creatorDuarte, Giuliano Mendes
dc.creatorCabello, César
dc.creatorTorresan, Renato Zocchio
dc.creatorAlvarenga, Marcelo
dc.creatorTelles, Gilliat H Q
dc.creatorBianchessi, Susana Trigo
dc.creatorCaserta, Nelson
dc.creatorSegala, Silmara R
dc.creatorde Lima, Mariana da Cunha Lopes
dc.creatorEtchebehere, Elba Cristina Sá de Camargo
dc.creatorCamargo, Edwaldo E
dc.creatorTinois, Eduardo
dc.date2007-Oct
dc.date2015-11-27T13:10:18Z
dc.date2015-11-27T13:10:18Z
dc.date.accessioned2018-03-29T01:05:11Z
dc.date.available2018-03-29T01:05:11Z
dc.identifierAnnals Of Surgical Oncology. v. 14, n. 10, p. 2903-10, 2007-Oct.
dc.identifier1068-9265
dc.identifier10.1245/s10434-007-9476-7
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/17632758
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/197383
dc.identifier17632758
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1297616
dc.descriptionTo achieve a more specific method to estimate the real size of breast cancer, we have developed a method to fuse magnetic resonance imaging (MRI) and scintimammography (SM) images. The aim of this study was to assess the feasibility of this method and to evaluate its accuracy to measure the size of breast cancer compared with MRI alone, mammography, and clinical examination, employing pathologic size as the gold standard. Twenty consecutive breast cancer women at stages IIA-IIIA, scheduled for mastectomies, underwent SM with (99m)Tc-sestamibi and MRI with gadolinium 2-10 days before surgery. All patients had had recent mammographies and were examined clinically. Software was developed in visual language to perform the fusion between MRI and SM images and tumor measurements (MRI/SM). The tumor size, in 3 diameters (anteroposterior, longitudinal, and transverse), for each examination was correlated with pathological measurements using linear regression. The MRI/SM technique was successfully performed in all patients, and the principal tumor was measured by this method. The MRI/SM cancer measurements correlated better with pathology than MRI, mammography, and clinical exam in all diameters analyzed (r = 0.88, 0.81, 0.81; SE = 0.11, 0.14, 0.11 in anteroposterior, longitudinal, and transverse diameters, respectively). The MRI/SM is a feasible technique and appears to be more accurate than other examinations (MRI alone, mammography, and clinical exam) to measure breast cancer size.
dc.description14
dc.description2903-10
dc.languageeng
dc.relationAnnals Of Surgical Oncology
dc.relationAnn. Surg. Oncol.
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAdult
dc.subjectAged
dc.subjectBreast
dc.subjectBreast Neoplasms
dc.subjectCarcinoma, Ductal, Breast
dc.subjectFeasibility Studies
dc.subjectFemale
dc.subjectHumans
dc.subjectImage Enhancement
dc.subjectImage Processing, Computer-assisted
dc.subjectImaging, Three-dimensional
dc.subjectMagnetic Resonance Imaging
dc.subjectMammography
dc.subjectMastectomy
dc.subjectMiddle Aged
dc.subjectNeoplasm Staging
dc.subjectPilot Projects
dc.subjectRadionuclide Imaging
dc.subjectSensitivity And Specificity
dc.subjectSoftware
dc.subjectTechnetium Tc 99m Sestamibi
dc.titleFusion Of Magnetic Resonance And Scintimammography Images For Breast Cancer Evaluation: A Pilot Study.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución